(Q41126917)

27 September 2017

title

Distinction of CYP1A1 and CYP1A2 activity by selective inhibition using fluvoxamine and isosafrole (English)

1 reference

27 September 2017

1 reference

Pastrakuljic A

1

1 reference

27 September 2017

Tang BK

series ordinal

2

1 reference

27 September 2017

Roberts EA

series ordinal

3

1 reference

27 September 2017

Kalow W

series ordinal

4

1 reference

27 September 2017

language of work or name

English

0 references

publication date

1 February 1997

1 reference

27 September 2017

published in

Biochemical Pharmacology

1 reference

27 September 2017

volume

53

1 reference

27 September 2017

issue

4

1 reference

27 September 2017

page(s)

531-538

1 reference

The human hepatic cytochromes P450 involved in drug metabolism

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900769-1

In vitro methods for assessing human hepatic drug metabolism: their use in drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900769-1

Differential expression and regulation of members of the cytochrome P450IA gene subfamily in human tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900769-1

Expression of CYP1A1 and CYP1A2 genes in human liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900769-1

Selective in-vitro inhibition of hepatic oxidative metabolism by quinolones: 7-ethoxyresorufin and caffeine as model substrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900769-1

Development of a human lymphoblastoid cell line constitutively expressing human CYP1A1 cDNA: substrate specificity with model substrates and promutagens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900769-1

Evaluation of triacetyloleandomycin, alpha-naphthoflavone and diethyldithiocarbamate as selective chemical probes for inhibition of human cytochromes P450.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900769-1

Characterization of the inhibition of P4501A2 by furafylline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900769-1

Fluvoxamine is a potent inhibitor of cytochrome P4501A2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900769-1

Interaction between fluvoxamine and imipramine/desipramine in four patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900769-1

Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: potent inhibition by fluvoxamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900769-1

Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900769-1

10.1016/S0006-2952(96)00769-1

7 January 2021

Identifiers

DOI

1 reference

27 September 2017

1 reference